Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
84pct
126d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Yes
479
No
366
Present
0
Not Voting
31
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (14)
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).
HousePassed/agreed to in House: On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).
HouseThe House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.
The previous question was ordered pursuant to the rule.
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 467.
The House resolved into Committee of the Whole House on the state of the Union for further consideration.
Considered as unfinished business. (consideration: CR H2605-2607)
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| #236 | house | On Agreeing to the Amendment | Failed | May 25, 2023 |
| #237 | house | On Passage | Passed | May 25, 2023 |
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930 / S. 5266; supporting the FAIR Act, H.R. 1525 / S. 5512; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985;supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons, opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; opposing proposed BOP rule to ban the use of social media by incarcerated persons; supporting the Prohibiting Punishment of Acquitted Conduct Ave, S. 2788 and H.R. 5430; opposing the Combating Illicit Xylazine Act, H.R. 1839 and S. 993; supporting the Driving for Opportunity Act, S. 2313; opposing the SHIELD Act, S. 412 and H.R. 3686; opposing proposed appropriations cuts to the federal indigent defense system; supporting the Reentry Act (H.R.2400 / S.1165) and Due Process Continuity of Care Act (H.R.3074 / S.971); and supporting the implementation of tobacco harm reduction policies.
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule; S. 4685 and H.R. 4664 - Financial Services; General Government FY 2025 Appropriations; H.R.9835 - Sexual Abuse Services in Detention Act (SASIDA)
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule; S. 4685 and H.R. 4664 - Financial Services and General Government FY 2024 Appropriations
Client expense: $25,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Social Security Fairness Act; The FORCE Act; The HELPER Act; Providing Child Care for Police Officers Act (H.R. 2722, S. 3884); Recruit and Retain Act (H.R. 3325, S. 546); Strong Communities Act (H.R. 5029, S. 994); Investing in Community Safety Act (H.R. 4246); Supporting the Health and Safety of Law Enforcement Act (H.R. 4911); Qualified Immunity Act (H.R. 233); The Invest to Protect Act (H.R. 3184, S. 1144); HALT Fentanyl Act (H.R. 467, S. 1141); Combatting Illicit Xylazine Act (H.R. 1839, S. 993); Combatting Organized Retail Crime Act (H.R. 895, S. 140).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Committee of the Whole House on the state of the Union rises leaving H.R. 467 as unfinished business.
On motion that the committee rise Agreed to by voice vote.
Mr. Bucshon moved that the committee rise.
POSTPONED PROCEEDINGS - At the conclusion of debate on the Pettersen amendment No. 3, the Chair put the question on adoption of the amendment and by voice vote, announced that the noes had prevailed. Mr. Pallone demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
DEBATE - Pursuant to the provisions of H. Res. 429, the Committee of the Whole proceeded with 10 minutes of debate on the Pettersen amendment No. 3.
DEBATE - Pursuant to the provisions of H. Res. 429, the Committee of the Whole proceeded with 10 minutes of debate on the Mills amendment No. 2.
DEBATE - Pursuant to the provisions of H. Res. 429, the Committee of the Whole proceeded with 10 minutes of debate on the Miller (OH) amendment No. 1.
Considered as unfinished business. (consideration: CR H2602-2605)
Committee of the Whole House on the state of the Union rises leaving H.R. 467 as unfinished business.
On motion that the committee rise Agreed to by voice vote.
Mr. Guthrie moved that the committee rise.
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 467.
The Speaker designated the Honorable Marjorie Taylor Greene to act as Chairwoman of the Committee.
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 429 and Rule XVIII.
Rule provides for consideration of H.R. 467, S.J. Res. 11 and H.J. Res. 45. The resolution provides for consideration of H.R. 467 under a structured rule with one of hour of general debate. S.J. Res. 11 and H.J. Res. 45 are considered under closed rules with one hour of general debate. Motion to recommit provided on H.R. 467 and H.J. Res. 45, and one motion to commit on S.J. Res. 11.
Considered under the provisions of rule H. Res. 429. (consideration: CR H2579-2587)
Rules Committee Resolution H. Res. 429 Reported to House. Rule provides for consideration of H.R. 467, S.J. Res. 11 and H.J. Res. 45. The resolution provides for consideration of H.R. 467 under a structured rule with one of hour of general debate. S.J. Res. 11 and H.J. Res. 45 are considered under closed rules with one hour of general debate. Motion to recommit provided on H.R. 467 and H.J. Res. 45, and one motion to commit on S.J. Res. 11.
Placed on the Union Calendar, Calendar No. 47.
Committee on the Judiciary discharged.
Committee on the Judiciary discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-67, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by the Yeas and Nays: 27 - 19.
Committee Consideration and Mark-up Session Held.
Subcommittee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 17 - 10 .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Markup By |
| March 24, 2023 |
| Judiciary Committee | House | Referred To | January 24, 2023 |
| Energy and Commerce Committee | House | Referred To | January 24, 2023 |
| January 24, 2023 |
| Republican |
| NY |
| August Pfluger | Republican | TX |
| Austin Scott | Republican | GA |
| Ben Cline | Republican | VA |
| Brad Finstad | Republican | MN |
| Brett Guthrie | Republican | KY |
| Bruce Westerman | Republican | AR |
| Carol D. Miller | Republican | WV |
| Cathy McMorris Rodgers | Republican | WA |
| Chuck Edwards | Republican | NC |
| Dan Crenshaw | Republican | TX |
| Daniel Meuser | Republican | PA |
| Debbie Lesko | Republican | AZ |
| Diana Harshbarger | Republican | TN |
| Earl L. "Buddy" Carter | Republican | GA |
| Gary J. Palmer | Republican | AL |
| Greg Pence | Republican | IN |
| Gus M. Bilirakis | Republican | FL |
| Harold Rogers | Republican | KY |
| Jay Obernolte | Republican | CA |
| Jeff Duncan | Republican | SC |
| Jefferson Van Drew | Republican | NJ |
| Jerry L. Carl | Republican | AL |
| Jim Banks | Republican | IN |
| John Joyce | Republican | PA |
| John R. Carter | Republican | TX |
| John R. Curtis | Republican | UT |
| John R. Moolenaar | Republican | MI |
| Juan Ciscomani | Republican | AZ |
| Kat Cammack | Republican | FL |
| Kelly Armstrong | Republican | ND |
| Larry Bucshon | Republican | IN |
| Lori Chavez-DeRemer | Republican | OR |
| Mariannette Miller-Meeks | Republican | IA |
| Michael C. Burgess | Republican | TX |
| Mike Bost | Republican | IL |
| Mike Garcia | Republican | CA |
| Neal P. Dunn | Republican | FL |
| Nicholas A. Langworthy | Republican | NY |
| Richard Hudson | Republican | NC |
| Rick W. Allen | Republican | GA |
| Robert E. Latta | Republican | OH |
| Scott Fitzgerald | Republican | WI |
| Stephanie I. Bice | Republican | OK |
| Steve Womack | Republican | AR |
| Tim Burchett | Republican | TN |
| Tim Walberg | Republican | MI |
| Troy Balderson | Republican | OH |
| Vern Buchanan | Republican | FL |
| HR 568 |
118th |
| Related bill |
| HR 3629 | 118th | Related bill |
| HR 171 | 118th | Identical bill |
| HR 1580 | 118th | Related bill |
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Mental Health Substance Use Disorder related issues H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · fourth_quarter · Alcohol and Drug Abuse
H.R.4531, SUPPORT Act, Reauthorization related issues Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Mental Health Substance Use Disorder related issues Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
- Safer Detention Act (S. 1248), legislation to expand elderly home confinement and compassionate release eligibility within the Bureau of Prisons - EQUAL Act (S. 524), a bill to eliminate the sentencing disparity between crack and powder cocaine - HALT Fentanyl Act (HR 467)- bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act - TEST Act (S. 1950) - extend the temporary class-wide scheduling for two years during which time the Department of Justice will be required to conduct a scientific and medical evaluation of the fentanyl-related substances it has encountered to date but not yet tested, also eases research requirements so that the science and medical communities can study and develop treatments for fentanyl-related substances. - Appropriations advocacy to rescind funding for a proposed federal prison in eastern Kentucky and fully fund the federal defenders (no specific bill)
Client expense: $19,049 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Kenneth P. Thompson Begin Again Act (S. 2596 / H.R. 4958); Keeping Violent Offenders Off our Streets Act (H.R. 8205); Inclusive Democracy Act (S. 3423, H.R. 6643); Clean Slate Act (H.R. 2930); Reentry Act (H.R.2400 / S.1165); Due Process Continuity of Care Act (H.R. 3074 / S.971); Fentanyl related substances and HALT Fentanyl Act (S. 1141 / H.R. 467); Weldon Angelos Presidential Pardon Expungements Act (H.R.10248); True Justice Act (H.R. 10496); Federal Public Defense Commission Act (S. 5526 / H.R. 10379); Rates for Interstate Inmate Calling Service; Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R.5601); Cannabis Administration and Opportunity Act (CAOA) (S.4226); Right to Trial Act (H.R. 8856); SHIELD Act (S. 412; H.R. 3686); U.S. Sentencing Commission nominations; Fourth Amendment is Not for Sale Act (S. 2576 / H.R. 4639); National Defense Authorization Act
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; opposing proposed BOP rule to ban the use of social media by incarcerated persons; supporting the Prohibiting Punishment of Acquitted Conduct Ave, S. 2788 and H.R. 5430; opposing the Combating Illicit Xylazine Act, H.R. 1839 and S. 993; supporting the Driving for Opportunity Act, S. 2313; opposing the SHIELD Act, S. 412 and H.R. 3686; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; and supporting the implementation of tobacco harm reduction policies.
Client expense: $20,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule; S. 4685 and H.R. 4664 - Financial Services and General Government FY 2024 Appropriations
Client expense: $110,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
Social Security Fairness Act; The FORCE Act; The HELPER Act; Providing Child Care for Police Officers Act (H.R. 2722, S. 3884); Recruit and Retain Act (H.R. 3325, S. 546); Strong Communities Act (H.R. 5029, S. 994); Investing in Community Safety Act (H.R. 4246); Supporting the Health and Safety of Law Enforcement Act (H.R. 4911); Qualified Immunity Act (H.R. 233); The Invest to Protect Act (H.R. 3184, S. 1144); HALT Fentanyl Act (H.R. 467, S. 1141); Combatting Illicit Xylazine Act (H.R. 1839, S. 993); Combatting Organized Retail Crime Act (H.R. 895, S. 140).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Monitor the following: Barriers to research resulting from DEA scheduling, Drug research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Alcohol and Drug Abuse
Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
- Safer Detention Act (S. 1248), legislation to expand elderly home confinement and compassionate release eligibility within the Bureau of Prisons - EQUAL Act (S. 524), a bill to eliminate the sentencing disparity between crack and powder cocaine - HALT Fentanyl Act (HR 467)- bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act - TEST Act (S. 1950) - extend the temporary class-wide scheduling for two years during which time the Department of Justice will be required to conduct a scientific and medical evaluation of the fentanyl-related substances it has encountered to date but not yet tested, also eases research requirements so that the science and medical communities can study and develop treatments for fentanyl-related substances. - Appropriations advocacy to rescind funding for a proposed federal prison in eastern Kentucky and fully fund the federal defenders (no specific bill)
Client expense: $39,817 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; and opposing proposed BOP rule to ban the use of social media by incarcerated persons.
Client expense: $30,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Social Security Fairness Act; The FORCE Act; The HELPER Act; Providing Child Care for Police Officers Act (H.R. 2722, S. 3884); Recruit and Retain Act (H.R. 3325, S. 546); Strong Communities Act (H.R. 5029, S. 994); Investing in Community Safety Act (H.R. 4246); Supporting the Health and Safety of Law Enforcement Act (H.R. 4911); Qualified Immunity Act (H.R. 233); The Invest to Protect Act (H.R. 3184, S. 1144); HALT Fentanyl Act (H.R. 467, S. 1141); Combatting Illicit Xylazine Act (H.R. 1839, S. 993); Combatting Organized Retail Crime Act (H.R. 895, S. 140).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding the emergency class-wide scheduling of fentanyl analogues; Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule; S. 4685 and H.R. 4664 - Financial Services and General Government FY 2024 Appropriations; and H.R. 7530 - DC CRIMES Act
Client expense: $250,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
2024 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Monitor the following: Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Alcohol and Drug Abuse
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; opposing S.J.Res. 47 and H.J.Res.97, which would undo CARES Act home confinement; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; and opposing proposed BOP rule to ban the use of social media by incarcerated persons.
Client expense: $30,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 130, the "Thin Blue Line Act," legislation to amend title 18, United States Code, to provide additional aggravating factors for the imposition of the death penalty based on the status of the victim; entire bill. H.R. 1525, the "FAIR Act," a bill to revise federal civil and criminal forfeiture laws; entire bill. H.R. 354, the "LEOSA Reform Act," a bill to amend title 18, United States Code, to improve the Law Enforcement Officer Safety Act and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. H.R. 355, the "Back the Blue Act," a bill to enhance protections for law enforcement officers and to revise the Law Enforcement Officers Safety Act of 2004; entire bill. H.R. 4639, the "Fourth Amendment is Not for Sale Act," legislation to amend section 2702 of title 18, United States Code, to prevent law enforcement and intelligence agencies from obtaining subscriber or customer records in exchange for anything of value, and address communications and records in the possession of intermediary internet service providers; entire bill. H.R. 467, the "HALT Fentanyl Act," a bill to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances; entire bill. H.R. 743, the "Protect and Serve Act," a bill to amend title 18, United States Code, to punish criminal offenses targeting law enforcement officers; entire bill. H.R. 7888, the "Reforming Intelligence and Securing America Act," legislation to reform the Foreign Intelligence Surveillance Act of 1978; proposed House amendment to prevent law enforcement and intelligence agencies from obtaining subscriber or customer records in exchange for anything of value, and address communications and records in the possession of intermediary internet service providers; S. Amdt. 1829, to prevent law enforcement and intelligence agencies from obtaining subscriber or customer records in exchange for anything of value, and address communications and records in the possession of intermediary internet service providers. H.R. 8146, the "Police Our Border Act," a bill to require a report by the Attorney General on the impact the border crisis is having on law enforcement at the Federal, State, local, and Tribal level; entire bill. H.R. 8587, the "Paula Bohovesky and Joan D'Alessandro Act," a bill to amend title 18, United States Code, to increase the scope of the penalty for crimes against children; entire bill. H.R. 8818, the "American Privacy Rights Act," a bill to establish a federal data privacy standard; entire bill. Legislative proposal to permanently extend DEA's authority to list fentanyl analogues in Schedule I of the Controlled Substances Act (no bill introduced). S. 1141, the "HALT Fentanyl Act," legislation to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances; entire bill. S. 1462, the "LEOSA Reform Act," a bill to amend title 18, United States Code, to improve the Law Enforcement Officer Safety Act and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. S. 1569, the "Back the Blue Act," a bill to enhance protections for law enforcement officers and to revise the Law Enforcement Officers Safety Act of 2004; entire bill. S. 4258, the "Protect and Serve Act," a bill to amend title 18, United States Code, to punish criminal offenses targeting law enforcement officers; entire bill. H.R. 7343, the "Detain and Deport Illegal Aliens Who Assault Cops Act," a bill to amend the Immigration and Nationality Act to provide for the detention of certain aliens who commit assault against law enforcement officers; entire bill.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
- Safer Detention Act (S. 1248), legislation to expand elderly home confinement and compassionate release eligibility within the Bureau of Prisons - EQUAL Act (S. 524), a bill to eliminate the sentencing disparity between crack and powder cocaine - HALT Fentanyl Act (HR 467)- bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act - TEST Act (S. 1950) - extend the temporary class-wide scheduling for two years during which time the Department of Justice will be required to conduct a scientific and medical evaluation of the fentanyl-related substances it has encountered to date but not yet tested, also eases research requirements so that the science and medical communities can study and develop treatments for fentanyl-related substances. - Appropriations advocacy to rescind funding for a proposed federal prison in eastern Kentucky and fully fund the federal defenders (no specific bill) - Lobbying against the DC Crimes Act (H.R.7530) which would remove the DC Council's ability to modify sentencing laws under the Home Rule Act and restrict eligibility for the Youth Rehabilitation Act. - Lobbying against the Cares Act Home Confinement Disapproval Resolution (S.J. Res. 47) - which would block regulatory changes to the home confinement pursuant to the CARES Act from going into effect.
Client expense: $61,271 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Appropriations for Federal Defender Services (Financial Services and General Government); Access to counsel & discovery in federal pretrial detention; Resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Justice relating to "Office of the Attorney General; Home Confinement Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act" (S.J. Res. 47 / H.J. Res. 97); Federal Prison Oversight Act (S. 1401 / H.R.3019); Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R.5601); Cannabis Administration and Opportunity Act (CAOA) (S.4226); HALT Fentanyl Act (H.R.467); Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act (S. 1950); proposed amendments to the US Sentencing Guidelines; Federal restitution law, Right to Trial Act (H.R. 8856); FAIR Act (H.R. 1525); Fourth Amendment is Not for Sale Act (S. 2576 / H.R. 4639); National Defense Authorization Act; 702 reauthorization; Reforming Intelligence and Securing America Act (H.R. 7888)
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Comment on Sentencing Commission acquitted conduct amendment Concerns about S.1306, COPS Reauthorization Act of 2023 Concerns about White House public safety agenda Concerns surrounding policing bills: H.R. 5798 EO 14074 Policing Executive Order Implementation of Public Law No: 113-242 the Death in Custody Reporting Act Improving hate crime data collection and reporting, Improving Reporting to Prevent Hate Act (H.R.7648) Oppose H.R. 467, HALT Fentanyl Act Oppose S.1080 - Cooper Davis Act Oppose S.1199, the STOP CSAM Act of 2023 Oppose S.140, Combating Organized Retail Crime Act of 2023 Oppose S.412, the SHIELD Act of 2023 Public Law No. 117-12 Oppose Extending Emergency Scheduling of Fentanyl Analogues Support Abolishing Mandatory Minimums / Sentencing Reform
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Social Security Fairness Act; The FORCE Act; The HELPER Act; Providing Child Care for Police Officers Act (H.R. 2722, S. 3884); Recruit and Retain Act (H.R. 3325, S. 546); Strong Communities Act (H.R. 5029, S. 994); Investing in Community Safety Act (H.R. 4246); Supporting the Health and Safety of Law Enforcement Act (H.R. 4911); Qualified Immunity Act (H.R. 233); The Invest to Protect Act (H.R. 3184, S. 1144); HALT Fentanyl Act (H.R. 467, S. 1141); Combatting Illicit Xylazine Act (H.R. 1839, S. 993); Combatting Organized Retail Crime Act (H.R. 895, S. 140).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Monitor Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · first_quarter · Alcohol and Drug Abuse
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) S.3921, Medicaid Bump Act, Entirety Monitor the following: Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Practice Support/Grants to Practice S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act: Ambulatory Surgical Centers H.R.6205, Healthcare Workforce Resilience Act: physician workforce H.R.7591, National Patient Safety Board Act of 2024: patient safety S.1302, Resident Physician Shortage Reduction Act of 2023: residency positions S.665, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status Medical liability H.Res. 734: Expressing support for the designation of October 1 as "National Latino and Latina Physician Day" S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas Public Law No. 113-5, Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA): preparedness for public health H.R. 467, HALT Act: scheduling of fentanyl-related substances H.R. 7259, Medical Controlled Substances Transportation Act of 2022: to enable physicians to more easily transport controlled substances safely and legally across state lines H.R. 133, the Consolidated Appropriations Act, 2021: No Surprises Act, surprise medical billing H.R. 2630, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act: Opioids H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills S. 445, Mainstreaming Addiction Treatment Act of 2021: Opioids H.R. 4387, Maternal Health Quality Improvement Act of 2021: Maternal health H.R. 1565, Saving Lives, Saving Costs S. 1475, Saving Lives, Saving Costs S. 610, Dr. Lorna Breen Health Care Provider Protection Act: Physician wellness H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act: Physician wellness S. 987, CARA 3.0 Act of 2021: Opioids H.R. 3259, NOPAIN Act: Opioids S. 586, NOPAIN Act: Opioids S. 1292, Non-Opioid Directive Act: Opioids H.R. 7961, SAVE Act: To protect hospital personnel from violence, and for other purposes. H.R.833, Save America's Rural Hospitals: rural pass through H.R.1492, Medical Controlled Substances Transportation Act of 2017: medical controlled substances transportation Pre-authorization; prior authorization Affordable Care Act reform efforts 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care Resident Education Deferred Interest Act (REDI Act): Student loan relief Student Loan Forgiveness for Frontline Health Workers Act: Student loan relief 21st Century Cures Initiative H.R. 4369, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act: Drug shortages DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Ketamine use by law enforcement Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health Certified Anesthesiologist Assistants Blood management Long COVID research Anesthesia workforce shortages CDC Opioid Prescribing Guideline 2023 Labor/HHS/Education appropriations bill Defense Health Agency anesthesia policy Change Healthcare data breach Maternal Mortality/Maternal Care Deserts
Client expense: $290,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding the emergency class-wide scheduling of fentanyl analogues; Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule; S. 4685 and H.R. 4664 - Financial Services and General Government FY 2024 Appropriations; and H.R. 7530 - DC CRIMES Act
Client expense: $100,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
- Safer Detention Act (S. 1248), legislation to expand elderly home confinement and compassionate release eligibility within the Bureau of Prisons - EQUAL Act (S. 524), a bill to eliminate the sentencing disparity between crack and powder cocaine - HALT Fentanyl Act (HR 467)- bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act - TEST Act (S. 1950) - extend the temporary class-wide scheduling for two years during which time the Department of Justice will be required to conduct a scientific and medical evaluation of the fentanyl-related substances it has encountered to date but not yet tested, also eases research requirements so that the science and medical communities can study and develop treatments for fentanyl-related substances. - Appropriations advocacy to rescind funding for a proposed federal prison in eastern Kentucky and fully fund the federal defenders (no specific bill) - Lobbying against the DC Crimes Act (H.R.7530) which would remove the DC Council's ability to modify sentencing laws under the Home Rule Act and restrict eligibility for the Youth Rehabilitation Act. - Lobbying against the Cares Act Home Confinement Disapproval Resolution (S.J. Res. 47) - which would block regulatory changes to the home confinement pursuant to the CARES Act from going into effect.
Client expense: $42,737 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; opposing S.J.Res. 47 and H.J.Res.97, which would undo CARES Act home confinement; supporting Small Business Administrations proposed rule to eliminate existing criminal background requirements for SBA-backed loan and surety programs for small business owners; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general.
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Social Security Fairness Act; The FORCE Act; The HELPER Act; Providing Child Care for Police Officers Act (H.R. 2722); Recruit and Retain Act (H.R. 3325, S. 546); Strong Communities Act (H.R. 5029, S. 994); Investing in Community Safety Act (H.R. 4246); Supporting the Health and Safety of Law Enforcement Act (H.R. 4911); Qualified Immunity Act (H.R. 233); The Invest to Protect Act (H.R. 3184, S. 1144); HALT Fentanyl Act (H.R. 467, S. 1141); Combatting Illicit Xylazine Act (H.R. 1839, S. 993); Combatting Organized Retail Crime Act (H.R. 895, S. 140).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
H.R. 830, Help Ensure Lower Patient (HELP) Copays Act, All provisions S. 1375, Help Ensure Lower Patient (HELP) Copays Act, all provisions H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act of 2023, all provisions H.R. 1359, Modernizing Opioid Treatment Access Act, all provisions S. 644, Modernizing Opioid Treatment Access Act, all provisions H.R. 2630, Safe Step Act, all provisions S. 652, Safe Step Act, all provisions H.R. 2923, Living Donor Protection Act of 2023, all provisions S. 1384, Living Donor Protection Act of 2023, all provisions H.R. 3752, Parity Enforcement Act of 2023, all provisions S. 2840, Bipartisan Primary Care and Health Workforce Act, all provisions H.R. 6487, No Fees for EFTs Act, all provisions S. 2666, EPCS 2.0 Act, all provisions H.R. 4507, Transparency in Coverage Act of 2023, all provisions H.R. 4508, Hidden Fee Disclosure Act of 2023, all provisions H.R. 6033, Supporting Patient Education And Knowledge (SPEAK) Act of 2023, provisions relating to telehealth/equity H.R. 6230, Doctor Knows Best Act of 2023, all provisions S. 2362, Drug Shortage Prevention Act of 2023, all provisions S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions H.R. 382, Pandemic is Over Act, all provisions H.R. 467, HALT Fentanyl Act, all provisions H.R. 3065, School Access to Naloxone Act of 2023, all provisions Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) Health Workforce Well-Being Day of Awareness/draft proposal Substance Use Disorder Workforce Act/draft Physical therapy care plans/physician approvals Provider Relief Fund recoupment Digital health/Augmented intelligence (AI) Physician workforce/scope of practice Nutrition Data privacy HIPAA/electronic records Overdose Epdemic Xylazine use/drug overdose deaths Opioid prescribing Testosterone/regulation/scheduling Physician gender equity/COVID-19 pandemic Health equity/persons with disabilities Health equity/Superfund sites Breast reconstruction codes/reimbursement and coverage Methotrexate/access and supply chain issues Street medicine/place-of-service code/homelessness and maternal health Mental health/physician burnout Prior authorization reform Released inmates recidivism/health care and social services Duty to care Reproductive health/over-the-counter birth control access Clinical algorithms/bias/discrimination Precision medicine Telehealth/permanent flexibility expansion Coding Health equity/Maternal health Reproductive health/data privacy
Client expense: $5,740,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Occupational Safety & Health Administration (OSHA), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of
2023 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding the emergency class-wide scheduling of fentanyl analogues; Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; H.J.Res.26 - Disapproving the action of the District of Columbia Council in approving the Revised Criminal Code Act of 2022; S.353 - PROTECT Act; S.1170 - Project Safe Childhood Act; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; and S.1401 and H.R.3019 - Federal Prison Oversight Act.
Client expense: $110,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding the emergency class-wide scheduling of fentanyl analogues; Issues regarding implementation of the CARES Act for people in BOP custody; United States Sentencing Commission Proposed Guideline Amendments; S.524 and H.R.1062 - EQUAL Act; S.1141 and H.R. 467 - HALT Fentanyl; S.1401 and H.R.3019 - Federal Prison Oversight Act; and S.J.R. 47, H.J. Res. 97, and Amendment #216 to H.R. 5893, House Commerce, Justice, Science and Related Agencies Appropriations Act FY 24 - Disapproval of DOJ CARES Act Home Confinement rule S. 4685 and H.R. 4664 - Financial Services and General Government FY 2024 Appropriations
Client expense: $140,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
2023 · fourth_quarter · Health Issues
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Monitor the following: Contingency Management, Protocol related issues Farm Bill 2023, Cannabidiol regulation
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2023 · fourth_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Contingency Management, Protocol related issues Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety 2023 Farm Bill, Cannabidiol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Alcohol and Drug Abuse
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Cannabidiol related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances 2023 Farm Bill, Cannabidiol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Concerns surrounding policing bills Oppose Cooper Davis Act Oppose Extending Emergency Scheduling of Fentanyl Analogues Oppose H.R. 467, HALT Fentanyl Act Oppose the SHIELD Act Oppose the STOP CSAM Act Policing Executive Order Support Abolishing Mandatory Minimums / Sentencing Reform Support funding for federal defenders Support mandatory hate crime data reporting
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
2023 · fourth_quarter · Health Issues
Practice Support/Grants to Practice S.665, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status Medical liability H.Res. 734: Expressing support for the designation of October 1 as "National Latino and Latina Physician Day" S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas Public Law No. 113-5, Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA): preparedness for public health H.R. 467, HALT Act: scheduling of fentanyl-related substances H.R. 7259, Medical Controlled Substances Transportation Act of 2022: to enable physicians to more easily transport controlled substances safely and legally across state lines H.R. 133, the Consolidated Appropriations Act, 2021: No Surprises Act, surprise medical billing H.R. 2630, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act: Opioids H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills S. 445, Mainstreaming Addiction Treatment Act of 2021: Opioids H.R. 4387, Maternal Health Quality Improvement Act of 2021: Maternal health H.R. 1565, Saving Lives, Saving Costs S. 1475, Saving Lives, Saving Costs S. 610, Dr. Lorna Breen Health Care Provider Protection Act: Physician wellness H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act: Physician wellness S. 987, CARA 3.0 Act of 2021: Opioids H.R. 3259, NOPAIN Act: Opioids S. 586, NOPAIN Act: Opioids S. 1292, Non-Opioid Directive Act: Opioids H.R. 7961, SAVE Act: To protect hospital personnel from violence, and for other purposes. H.R.833, Save America's Rural Hospitals: rural pass through H.R.1492, Medical Controlled Substances Transportation Act of 2017: medical controlled substances transportation FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Pre-authorization; prior authorization Affordable Care Act reform efforts 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care Resident Education Deferred Interest Act (REDI Act): Student loan relief Student Loan Forgiveness for Frontline Health Workers Act: Student loan relief H.R. 842, Protecting the Right to Organize Act of 2021: PRO Act, labor protections 21st Century Cures Initiative H.R. 4369, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act: Drug shortages DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Ketamine use by law enforcement Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health Certified Anesthesiologist Assistants Blood management Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, scope of Practice (waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Long COVID research Anesthesia workforce shortages CDC Opioid Prescribing Guideline 2023 Labor/HHS/Education appropriations bill Defense Health Agency anesthesia policy
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
- Safer Detention Act (S. 1248), legislation to expand elderly home confinement and compassionate release eligibility within the Bureau of Prisons - EQUAL Act (S. 524), a bill to eliminate the sentencing disparity between crack and powder cocaine - HALT Fentanyl Act (HR 467)- bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act - TEST Act (S. 1950) - extend the temporary class-wide scheduling for two years during which time the Department of Justice will be required to conduct a scientific and medical evaluation of the fentanyl-related substances it has encountered to date but not yet tested, also eases research requirements so that the science and medical communities can study and develop treatments for fentanyl-related substances. - Appropriations advocacy to rescind funding for a proposed federal prison in eastern Kentucky and fully fund the federal defenders (no specific bill)
Client expense: $32,763 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE